サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571462

避妊薬と避妊具の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2024年～2030年

Contraceptive Drugs And Devices Market Size, Share & Trends Analysis Report By Product (Contraceptive Drugs (Contraceptive Pills, Patch, Injectable), Contraceptive Devices), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.54円
避妊薬と避妊具の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2024年～2030年
出版日: 2024年09月06日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

避妊薬と避妊具の市場規模と動向：

世界の避妊薬と避妊具市場規模は2023年に296億米ドルとなり、2024年から2030年にかけてCAGR 5.9％で成長すると予測されます。

市場成長の背景には、性感染症（STD）や意図しない妊娠の増加があります。避妊に関する認識を広めるために政府が講じたイニシアティブの数が増加していることが、市場の成長をもたらしています。さらに、人口抑制に関する政府の政策も市場成長に寄与すると予想されます。

政府は、性病や妊娠中絶についての認識を広め、避妊薬と避妊具の助けを借りてそれらをどのように回避するかについて、多額の投資を行っています。政府はまた、家族計画についての認識を広めており、これは最終的に人口管理における政府の助けとなります。さらに、安全で効果的な避妊手段に対する需要が高まっているため、主な製薬会社は避妊薬と避妊具を改良するための研究開発に多額の投資を行っています。したがって、これらの要因がこの市場の成長に寄与しています。

特に中低所得地域における人口の増加は、避妊手段の普及につながり、市場の成長をもたらしています。性の健康と家族計画に関する意識の高まりに伴い、望まない妊娠への対処に役立つ効果的な避妊手段に対する需要が高まっています。さらに、都市化や、職業上の目標のために妊娠を遅らせるなどのライフスタイルの変化が、市場の成長に拍車をかけています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 避妊薬と避妊具市場の変数、動向、範囲

  • 市場イントロダクション/系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 避妊薬と避妊器具市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 避妊薬と避妊具市場： 製品の推定・動向分析

  • セグメントダッシュボード
  • 避妊薬と避妊具市場：製品別変動分析、2023年・2030年
  • 避妊薬
  • 避妊具

第5章 避妊薬と避妊具市場： 地域の推定・動向分析

  • 避妊薬と避妊器具の市場シェア、地域別、2023年・2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Abbvie, Inc.
    • Afaxys, Inc.
    • Agile Therapeutics
    • Bayer AG
    • China Resources（Holdings）Co., Ltd.
    • Church &Dwight Co., Inc.
    • Cupid Limited
    • Helm AG
    • Johnson &Johnson Services, Inc.
    • Organon Group of Companies
    • Pfizer Inc.
    • Veru, Inc.
    • Viatris Inc.
目次
Product Code: 978-1-68038-032-3

Contraceptive Drugs And Devices Market Size & Trends:

The global contraceptive drugs and devices market size was valued at USD 29.6 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. The market growth can be attributed to an increase in the number of sexually transmitted diseases (STDs) and unintended pregnancies. A growing number of initiatives taken by the governments to spread awareness about contraception have resulted in market growth. Furthermore, government policies on controlling the population are expected to contribute to market growth.

The government is investing heavily in spreading awareness of STDs and abortion and how they are avoided with the help of contraceptive drugs or devices. The government is also spreading awareness about family planning, which will ultimately help the government in population management. Furthermore, key pharmaceutical companies are investing heavily in research and development to upgrade contraceptive drugs and devices as there is an increased demand for safe and effective contraceptive measures. Therefore, these factors have contributed to the growth of this market.

The increase in the population, especially in the middle and low-income regions, has resulted in market growth, as there is a rise in the popularity of contraceptive measures. With the rise in awareness regarding sexual health and family planning, there is an increased demand for effective contraceptive measures that can help in dealing with unwanted pregnancies. Furthermore, urbanization and changes in lifestyle, such as delaying pregnancy due to professional goals, are adding to the growth of the market.

Global Contraceptive Drugs And Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global contraceptive drugs and devices market report based on product and region.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Contraceptive Drugs
    • Contraceptive Pills
    • Patch
    • Injectable
  • Contraceptive Devices
    • Condoms
    • Male Condoms
    • Female Condoms
    • Subdermal Implants
    • Intrauterine Devices (IUDs)
    • Copper IUDs
    • Hormonal IUDs
  • Vaginal Ring
  • Diaphragm
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Contraceptive Drugs and Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Contraceptive Drugs and Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Contraceptive Drugs
    • 4.3.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Contraceptive Pills
      • 4.3.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Patch
      • 4.3.3.1. Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Injectable
      • 4.3.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Contraceptive Devices
    • 4.4.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Condom
      • 4.4.2.1. Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Male Condom
        • 4.4.2.2.1. Male Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Female Condom
        • 4.4.2.3.1. Female Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Subdermal Implants
      • 4.4.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Intrauterine Devices (IUDs)
      • 4.4.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2. Copper IUDs
        • 4.4.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.3. Hormonal IUDs
        • 4.4.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Vaginal Ring
      • 4.4.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Diaphragm
      • 4.4.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Contraceptive Drugs and Devices Market Share, By Region, 2023 & 2030 (USD Billion)
  • 5.2. North America
    • 5.2.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Sweden
      • 5.3.8.1. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. Norway
      • 5.3.9.1. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Australia
      • 5.4.5.1. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Abbvie, Inc.
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/ Strategic Initiatives
    • 6.4.2. Afaxys, Inc.
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/ Strategic Initiatives
    • 6.4.3. Agile Therapeutics
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/ Strategic Initiatives
    • 6.4.4. Bayer AG
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/ Strategic Initiatives
    • 6.4.5. China Resources (Holdings) Co., Ltd.
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/ Strategic Initiatives
    • 6.4.6. Church & Dwight Co., Inc.
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/ Strategic Initiatives
    • 6.4.7. Cupid Limited
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/ Strategic Initiatives
    • 6.4.8. Helm AG
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/ Strategic Initiatives
    • 6.4.9. Johnson & Johnson Services, Inc.
      • 6.4.9.1. Participant's Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Recent Developments/ Strategic Initiatives
    • 6.4.10. Organon Group of Companies
      • 6.4.10.1. Participant's Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Recent Developments/ Strategic Initiatives
    • 6.4.11. Pfizer Inc.
      • 6.4.11.1. Participant's Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Recent Developments/ Strategic Initiatives
    • 6.4.12. Veru, Inc.
      • 6.4.12.1. Participant's Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Recent Developments/ Strategic Initiatives
    • 6.4.13. Viatris Inc.
      • 6.4.13.1. Participant's Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Recent Developments/ Strategic Initiatives